在前列腺特异性抗原升高男性活检前实施5分钟磁共振成像筛查方案
该研究前瞻性纳入52例前列腺特异性抗原升高且未活检男性,比较5分钟筛查方案(轴位T2WI联合同时多层扩散加权成像)与全诊断多参数MRI按PI-RADS v2评分的效果。两种方案均能成功完成诊断,筛查方案敏感度和特异度均为100%,与mpMRI标准无显著差异,可疑淋巴结在两种方案中均可检出。
要点
- 5分钟筛查方案(轴位T2WI联合DW-EPISMS)按PI-RADS v2可成功完成诊断,敏感度和特异度均为100%。
- 筛查方案与全诊断mpMRI的PI-RADS评分诊断性能无显著差异(P=1.0)。
- 可疑淋巴结在筛查方案与mpMRI方案中均可同等检出。
核心结论
- 对于前列腺特异性抗原升高、活检前的男性,5分钟MR筛查方案适用于临床常规,诊断性能与全诊断mpMRI方案相似。
研究设计与样本
- 前瞻性研究,经机构审查委员会批准,纳入52例前列腺特异性抗原升高且既往未活检的患者,在3T MRI系统上采集按PI-RADS推荐的全诊断mpMRI方案及同时多层加速扩散加权成像序列(DW-EPISMS),由两名阅片者独立评估。
关键影像表现/征象
- 筛查方案平均病灶大小1.2 cm,mpMRI方案平均病灶大小1.4 cm(P=0.4)。
- 35%(18/52)为PI-RADS IV/V类病灶。
- 3例患者报告可疑淋巴结为额外发现,筛查方案与mpMRI方案均可同等检出。
诊断标准与关键数值
- 按PI-RADS v2标准评估前列腺癌存在与否,筛查方案敏感度和特异度均为100%(两名阅片者),与mpMRI标准比较无显著差异(P=1.0)。
- 筛查方案仅提供轴位T2加权和DW-EPISMS图像;mpMRI方案按PI-RADS推荐采集并作为参考标准。
临床应用与阅片要点
- 在前列腺特异性抗原升高男性活检前,可考虑采用5分钟筛查方案(轴位T2WI联合DW-EPISMS)按PI-RADS v2进行前列腺癌筛查。
- 筛查方案中可疑淋巴结可作为额外发现被检出,阅片时应同时关注淋巴结情况。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The aims of this study were to establish a 5-minute magnetic resonance (MR) screening protocol for prostate cancer in men before biopsy and to evaluate effects on Prostate Imaging Reporting and Data System (PI-RADS) V2 scoring in comparison to a conventional, fully diagnostic multiparametric MR imaging (mpMRI) approach.
MATERIALS AND METHODS: Fifty-two patients with elevated prostate-specific antigen levels and without prior biopsy were prospectively included in this institutional review board-approved study. In all patients, an mpMRI protocol according to the PI-RADS recommendations was acquired on a 3 T MRI system. In addition, an accelerated diffusion-weighted imaging sequence was acquired using simultaneous multislice technique (DW-EPISMS). Two readers independently evaluated the images for the presence/absence of prostate cancer according to the PI-RADS criteria and for additional findings. In a first reading session, only the screening protocol consisting of axial T2-weighted and DW-EPISMS images was made available. In a subsequent reading session, the mpMRI protocol was assessed blinded to the results of the first reading, serving as reference standard.
RESULTS: Both readers successfully established a final diagnosis according to the PI-RADS criteria in the screening and mpMRI protocol. Mean lesion size was 1.2 cm in the screening and 1.4 cm in the mpMRI protocol (P = 0.4) with 35% (18/52) of PI-RADS IV/V lesions. Diagnostic performance of the screening protocol was excellent with a sensitivity and specificity of 100% for both readers with no significant differences in comparison to the mpMRI standard (P = 1.0). In 3 patients, suspicious lymph nodes were reported as additional finding, which were equally detectable in the screening and mpMRI protocol.
CONCLUSIONS: A 5-minute MR screening protocol for prostate cancer in men with elevated prostate-specific antigen levels before biopsy is applicable for clinical routine with similar diagnostic performance as the full diagnostic mpMRI approach.
引用
- Weiss J, Martirosian P, Notohamiprodjo M, et al. Implementation of a 5-Minute Magnetic Resonance Imaging Screening Protocol for Prostate Cancer in Men With Elevated Prostate-Specific Antigen Before Biopsy. Invest Radiol. 2018. PMID: 29077588. doi:10.1097/RLI.0000000000000427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。